EOLS Earnings & Financial Statements
Evolus, Inc.
$7.22
-$0.29(-3.86%)
55
Overall
40
Value
60
Tech
65
Quality
Market Cap
$496.04M
Volume
1.01M
52W Range
$3.86 - $9.31
Target Price
$15.75
EOLS earnings and financial statements: Evolus, Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly.
EOLS Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $297.18M | $266.27M | $202.09M | $148.62M | $99.67M |
| Cost of revenue | $100.07M | $83.97M | $64.51M | $55.89M | $43.53M |
| Operating income | -$32.66M | -$34.41M | -$49.23M | -$65.33M | -$44.41M |
| EBITDA | -$21.24M | -$23.85M | -$40.69M | -$59.64M | -$39.06M |
| Net income | -$51.64M | -$50.42M | -$61.69M | -$74.41M | -$46.81M |
| EPS (diluted) | $-0.80 | $-0.81 | $-1.08 | $-1.33 | $-0.94 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $225.87M | $232.57M | $189.00M | $177.98M | $257.48M |
| Total liabilities | $248.97M | $227.05M | $209.69M | $159.48M | $175.61M |
| Shareholders’ equity | -$23.11M | $5.52M | -$20.69M | $18.50M | $81.88M |
| Cash and equivalents | $53.83M | $86.95M | $62.84M | $53.92M | $146.26M |
| Long-term debt | $152.47M | $128.26M | $125.17M | $73.10M | $73.48M |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | -$42.27M | -$18.00M | -$34.01M | -$84.91M | -$33.39M |
| Capital expenditure | -$8.45M | -$4.82M | -$1.63M | -$2.94M | -$970.0K |
| Free cash flow | -$50.72M | -$22.82M | -$35.63M | -$87.85M | -$34.36M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | EOLS | $7.22 | -3.9% | 1.01M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |